Solid Biosciences (SLDB)
(Delayed Data from NSDQ)
$6.82 USD
-0.01 (-0.15%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $6.82 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Solid Biosciences Inc. has a market cap of $529.43M, which represents its share price of $6.83 multiplied by its outstanding shares number of 77.51M. As a small-cap company, SLDB's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SLDB 6.82 -0.01(-0.15%)
Will SLDB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SLDB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SLDB
Wall Street Analysts Believe Solid Biosciences (SLDB) Could Rally 198.18%: Here's is How to Trade
SLDB Stock Rallies 60% in a Month: Here's What You Should Know
SLDB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News
SLDB Stock Up as FDA Clears IND for SGT-212 in Friedreich's Ataxia
Other News for SLDB
Solid Biosciences (SLDB) Awards Restricted Stock Units to New Employees
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | SLDB Stock News
Solid Biosciences reports inducement grants under Nasdaq listing rule
Solid Biosciences (SLDB) Advances Gene Therapy with FDA Fast Track
Solid Biosciences gets FDA fast track status for heart disease therapy